Overview

A Study of Nipocalimab in Adult Participants With Active Systemic Lupus Erythematosus

Status:
Recruiting
Trial end date:
2024-05-28
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate the efficacy of nipocalimab versus placebo in participants with active systemic lupus erythematosus (SLE).
Phase:
Phase 2
Details
Lead Sponsor:
Janssen Research & Development, LLC